About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT07299097

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rar...

Lead sponsor: Takeda•10 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Takeda Contact

CONTACT

+1-877-825-3327 medinfoUS@takeda.com

Sponsors

Lead Sponsor

Takeda

The aim is to do epidemiology study in the core group thus the enrolment number is not applicable to this group, however approximately100 participants in the supplementary group (online survey).

Age

0 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\- Core Group:
•1. Participants with NT1 or NT2 following International Classification of Sleep Disorders, 3rd Edition (ICSD-3) or ICSD-3 text revision (ICSD-3-TR) criteria who are alive at any point during 2023 or 2024.
•2. Any age, ethnicity and nationality.
•3. Treated / under follow-up in the study site and residing in the hospitals' reference areas. Consideration will be given if participants have changed their address or reached adulthood.
•1. Confirmation to have a diagnosis of NT1 or NT2 by a specialist.
•2. Participants greater than equal to (≥) 18 years or parents of narcolepsy participants under 18 years of age.
•3. Any gender, ethnicity or nationality.
•4. Residence in Spain.

Exclusion Criteria

•1\. NT1 or NT2 participants who do not reside in the hospitals' reference areas.
•\- Supplementary Group:
•1\. Participants without a confirmed NT1 or NT2 diagnosis by a specialist.

Related studies

RECRUITINGPhase 3

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

NCT07363720 · Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy

RECRUITINGPhase 2/3

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

NCT05816382 · Narcolepsy Type 1

RECRUITINGPhase 2/3

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

NCT06767683 · Narcolepsy Type 1, Narcolepsy Type 2, and more

RECRUITINGPhase 2

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

NCT06952699 · Narcolepsy Type 2

Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population

NCT06292598 · Narcolepsy Type 1, Bacterial Translocation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 15, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment100

Start dateDec 2025

Last updatedMay 15, 2026

Condition

Narcolepsy Type 1 Narcolepsy Type 2

Locations shown

Hospital General de Castellón

Castellon, Castellon

Hospital de Navarra

Pamplona, Navarre

Hospital de la Ribera

Alzira, Valencia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions